Cefepime Injection, Powder, For Solution
Product Images NDC 60505-6145

This text appears to be a description of a medicine called Cefepime for Injection, USP, with instructions on how to use and store it. Each vial contains a gram of Cefepime and Largine, and the dosage instructions are not given. The text says that the vials should be stored at room temperature and protected from light, and that they should be diluted before intravenous infusion. The manufacturer of the medicine is also provided.*

This is a description of a pharmaceutical product - Cefepime for injection. It is a single-dose vial with National Drug Code (NDC) 6050561440. It is manufactured by Qilu Antibiotics Pharmaceutical Co. Ltd, and is distributed under the trademarks NOVAPLUS and Ni, which are registered trademarks of Novation, LLC. Each vial contains sterile cefepime, which is a hydrochloride, USP equivalent to 1 gram of cefepime and L-arginine. The product comes in a dry state and requires a suitable parenteral vehicle prior to intravenous infusion. The typical dosage should be consulted by reviewing the package insert. The product must be stored at 20-25°C (68-77°F) with limited exposure to light. The lot number for the product is provided with the expiration date format of EXP-MMAYYY, and its code number is 34160024704A.*

This is a description of a Cefepime injection medication sold in a single-dose vial with an NDC number. The medication is manufactured by Qilu Pharmaceutical Co, Ltd. and distributed under the brand name NOVAPLUS by Novation, LLC. The vial contains 1 gram of sterile Cefepime HCL, which requires a suitable parenteral vehicle before IV infusion. The medication should be protected from light and stored at 20°C to 25°C. The usage and dosage information can be found in the package insert. The LOT number is 8F0086A41 and the expiration is 04/2020, and the GTIN is 10360505614407.*

This appears to be a label or package insert for a medication called "Cefepime for Injection, USP". It recommends that the medication be administered via intravenous infusion and stored at controlled room temperature, protected from light. The dosage information is not provided on the label and should be found in the package insert. The medication was manufactured for a company Apotex and distributed by a company called Novation LLC under their registered trademark NOVAPLUS.*

This is a description of Cefepime for Injection, USP, provided in a Single-Dose Vial with the NDC number of 60505-6145-0. The product is manufactured by Qilu Pharmaceutical Co. Ltd in Jinan, China and distributed by Apotex Corp. under the trademark NOVAPLUS*. The contents are sterile Cefepime hydrochloride, USP equivalent to 2 grams of Cefepime with L-arginine for pH adjustment. The product contains a code number of 39102520403, and is advised to be stored in dry state at 20-25°C (68-77°F) and kept protected from light. The recommended dosage can be found in the package insert. The expiration date of the product is April 2020.*